SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-24-000238
Filing Date
2024-08-13
Accepted
2024-08-13 16:36:40
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgbp063024form10q.htm   iXBRL 10-Q 952524
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9481
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9481
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4221
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4098
6 EXHIBIT 10.1 ex10_1.htm EX-10.1 3031
7 EXHIBIT 10.2 ex10_2.htm EX-10.2 3229
  Complete submission text file 0001607062-24-000238.txt   4295556

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE rgbp-20240630.xsd EX-101.SCH 45721
9 XBRL CALCULATION FILE rgbp-20240630_cal.xml EX-101.CAL 41871
10 XBRL DEFINITION FILE rgbp-20240630_def.xml EX-101.DEF 149884
11 XBRL LABEL FILE rgbp-20240630_lab.xml EX-101.LAB 291543
12 XBRL PRESENTATION FILE rgbp-20240630_pre.xml EX-101.PRE 245242
57 EXTRACTED XBRL INSTANCE DOCUMENT rgbp063024form10q_htm.xml XML 537053
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 241202294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)